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It was revealed the overfilled genome region was 8q24.21.
Association with prostate cancer was found with 17 SNPs. 8 SNPs
had the intergenic localization: SRRM1P1–CCAT1 (rs16901979,
rs12682344, rs6983561, rs10505483) and CASC8–CASC11
(rs10090154, rs4242384, rs7837688, rs4242382); 9 SNPs – intragenic
location: PRNCR1 (rs1016343, rs1456315, rs13254738, rs13252298),
LOC101930033 (rs445114, rs16902094, rs10505477), CCAT2
(rs6983267), CASC8 (rs1447295).
The early development of the disease was associated with the
9 SNPs: 4 SNPs were located in genes, 5 SNPs had the intergenic
localization. It was noted among 9 SNPs 4 markers were in
11q13.3 region (rs7127900, rs7126629, rs7931342, rs11228583).
5 markers (rs6983267, rs10993994, rs7127900, rs7931342,
rs17632542) have found in prostate cancer patients and in group
of patients with early development.
The 7 SNPs had the association with PSA level (rs16856139,
rs12409639, rs10993994, rs3213764, rs1058205, rs1354774,
rs2735839). 1 SNP among them was located intergenic region
(KLK3–KLK2 rs2735839), 6 SNPs – were in genes (SLC45A3
rs16856139, rs12409639, MSMB rs10993994, ATF7I rs3213764,
KLK3 rs1058205, KLKP1 rs1354774). 2 SNPs from 7 (rs10993994,
rs2735839) had the relation to PSA level and to prostate cancer
patients. Polymorphic variant rs10993994, located near 50-UTR
MSMB gene, had the associations with prostate cancer patients,
patients with early start of disease and with PSA level.
In conclusion, the search of genetic markers of prostate cancer
development is actual inmodern oncology. These data will allow
to form the groups of patients with different outcome and prog-
nosis and perform the personalized therapy for every patient.
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Background: Intratumoral heterogeneity contributes signifi-
cantly to the effectiveness of cancer treatment and outcome (Ng
C.K., Pemberton H.N., Reis-Filho J.S., 2012). Previously the phe-
nomenon of intratumoral morphological heterogeneity was
demonstrated in breast cancer and it was found that the presence
of alveolar structures in breast tumors is associated with high fre-
quency of lymphogenic metastasis (Zavyalova M.V. et al., 2013a;
Zavyalova M.V. et al. 2013b; Denisov E.V. et al., 2014). Tumor
microenvironment (ME) is a key factor in determining the proper-
ties of the invasive and metastatic potential of the tumor and
seems to be also heterogeneous. Analysis of the ME in patients
with different solid tumors reveals that the majority of tumors
show a T cell–infiltrated phenotype. Macrophages, fibroblasts,
dendric cells etc. are also located in the ME and show their
effects. The aim of this work was to determine the expression
of key markers of cells which are presented in the ME of the var-
ious morphological structures.
Materials and methods: A 49 year-old patient (IC NST, luminal
A, T1NxMx, grade 2) was enrolled in this study. The ME of tubular
(hollow-like), alveolar (morula-like), trabecular, solid structures/
patterns, and discrete (small) groups of tumor cells were isolated
from invasive breast carcinoma NST (n = 1) using laser microdis-
section (PALM, Carl Zeiss). RNA was extracted using RNeasy Plus
Micro Kit (Qiagen, USA) according to the manufacturer’s instruc-
tions. cDNA was synthesized, ligated, and amplified using
QuantiTect Whole Transcriptome Kit (Qiagen, USA) according to
the manufacturer’s instructions. The gene expression of ALCAM,
Bcl6, CD3E, CD4, CHI3L2, CHID1, FAP, CD244, FoxP3, RORc, CD8,
GATA-3, TBX21, EPCAM, CD79, CD206, CD209, IL12, CXCL11, TGFb,
IL10 was analyzed using qRT-PCR and normalized to ACTB1 gene
and normal tissue.
Results: We showed the prevalence of gene expression in the
ME of alveolar and solid structures. At the same time only one
gene (GATA-3) was found to be expressed in the ME of trabecular
structures and discrete groups of tumor cells. In the ME of alveo-
lar structures we found transcripts involved in Th1-response
(CD3E, CD4 and CD8). In addition, expression of GATA-3, TGFb,
FAP (fibroblast marker) and CD79 (B-lymphocyte marker) genes
linked with the Th2-response was also shown in the ME of
alveolar structures. In the ME of solid structures we detected
expression of CD3E gene (lymphocyte marker), transcription
factors of Th1, Th2 and Th17 cells (TBX21, GATA-3 and RORc
genes, respectively), NK cell marker (CD244), fibroblast marker
(ALCAM), and IL12 gene.
Conclusion: The obtained data demonstrate heterogeneity of
the tumor microenvironment in invasive breast carcinoma NST.
Inflammatory (Th1-response) and anti-inflammatory (Th2) reac-
tions were observed both in the ME of alveolar and solid struc-
tures. The ME of trabecular structures and discrete groups of
cancer cells showed only inflammatory marker. Functional
activity of the ME of alveolar structures is determined by expres-
sion of TGFb gene, which is involved in anti-inflammatory
response, invasion and progression, while in the microenviron-
ment of solid structures IL-12 gene, a key cytokine of Th1
response is expressed.
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